Ozempic Shows Potential for Alcohol Addiction in Trial

By News Health
1 month Ago

(MedPage Today) — Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving in adults with alcohol use disorder (AUD), a phase II randomized trial showed.
At 9 weeks, semaglutide…

Source link : https://www.medpagetoday.com/psychiatry/addictions/114191

Author :

Publish date : 2025-02-12 18:44:07

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Future of Canadian Guidelines, Task Force in Doubt

Diabetes Study's Funding Yanked; Marriage-Obesity Link; CVS 'Menopause-Friendly'

Pembrolizumab-Olaparib Boosts PFS in Non-BRCA Ovarian Cancer

NICE Recommends Annual BMI Checks for Long-Term Conditions

'Reasonable precautions' could have stopped baby deaths

Later Cancer Diagnoses Increase Higher in Certain States